S. Xaviar

Calculation of the fragility index of randomized controlled trials in epilepsy published in twelve major journals

Saibal Das, S. Xaviar, S. Das, 2019, Epilepsy Research.

An Audit of the Quality of Reporting and Bias of Studies on Yoga in Epilepsy.

S. Xaviar, Saibal Das, Sayali C. Tiwari, 2022, Neurology India.

Indo-Swiss symposium on advances in pharmacogenomic strategies for implementation of personalized medicine.

Shathish Kumar, K. Ramasamy, S. Xaviar, 2020, Pharmacogenomics.

A Questionnaire based Cross-sectional Study to assess Knowledge, Attitude and Practice of Pharmacovigilance and Adverse Drug Reaction Reporting among Postgraduate Medical students in a Tertiary Care Teaching Hospital of South India

S. Xaviar, Pavithra M S, V. R., 2022, Research Journal of Pharmacy and Technology.

Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis.

S. Joshi, N. Chatterjee, S. Tripathi, 2023, Diabetes & metabolic syndrome.

A cross-sectional study evaluating the knowledge, attitude, and practice of evidence-based medicine among resident doctors of a health-care Institution of National Importance in India

Jayanthi Mathaiyan, S. Xaviar, Indumathi Prabath, 2023, Perspectives in clinical research.

A case of nimesulide induced toxic epidermal necrolysis

M. Ravichandran, S. Xaviar, 2020 .